comprehensive -WSS

comprehensive

author：entertainment 2025-09-29 21:14:04 - browse：663

Illumina building. -- biotech coverage from STAT — Adobe

LONDON — The European Union on Wednesday issued an antitrust fine of $475 million to the U.S. genetic sequencing giant Illumina for closing its acquisition of cancer detection company Grail before clearing it with regulators.

The fine amounts to nearly 10% of Illumina’s annual global revenue, which is the most the European Commission can penalize a company under its merger regulations. The commission called Illumina’s actions “an unprecedented and very serious infringement” of the EU’s policies, including the “cornerstone” that regulators review deals that can alter the market.

The commission also issued what it called a symbolic fine of 1,000 Euros, or about $1,100, to Grail for what it said was the firm’s “active role” in the deal’s infringement of EU rules.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The high cost of giving birth even with insurance
Next article： Patients' immediate access to test results puts radiologists in a bind

WSS

Senators tussle over abortion against the backdrop of a presidential campaign

What PEPFAR has meant on the ground in Ukraine

Take antibiotics after sex, CDC recommends for certain risk groups

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

Elevance PBM president out as customers face prescription chaos

FDA needs staff influx to meet gene therapy needs, Marks says

hotspot

comprehensive

knowledge

Malaria cases in Florida and Texas: Here’s what you need to know

'Little Tech' descents on D.C., wanting a say in how AI is regulated

FDA approval of Sarepta Duchenne genetic therapy gives me hope

STAT wants to know your pick for a great summer read or listen

Cancer drug shortages should be causing more outrage

CMS got Medicare Advantage quality rating wrong, judge rules

Medicare proposal to cover medical devices draws a mixed reaction

Americans' trust in science, scientist continues decline: Report

Jerome Adams on the need for new antivirals for Covid

SCOTUS to consider access to abortion pill mifepristone

hotspot

Radiology is caught between AI's potential and concern for patients

Finland to offer bird flu vaccine to select groups of people, a possible global first

Pharma patents targeted by Biden in move to slash drug prices

ASCO Takeaways: Winners, snoozers, and the art of cancer care

FDA needs staff influx to meet gene therapy needs, Marks says

Teach medical students about patients with intellectual disabilities

focus

focus

focus

Wikipedia